Medina-Valentón E, Salgado-López DG, López-Morales CM

Language: Spanish
References: 13
Page: 80-84
PDF size: 259.73 Kb.

ABSTRACT

Introduction: All newborns born before 34 weeks of gestation are at risk of retinopathy of prematurity; however, the risk increases the lower the weight and gestational age. There are only a few studies in Mexico, but the prevalence is estimated between 10 and 28%. The aim of this article is to describe the frequency of ROP in a second level hospital. Material and methods: We reviewed retrospectively the experience of the ophthalmologic evaluation for detection of ROP. It was carried out on infants of ≤ 34 weeks of gestational age (WGA) and birth weight ≤ 1,750 grams who were hospitalized in the neonatal intensive care unit or in non-severe premature area. Results: A total of 121 cases of newborns at risk were analyzed; ROP was diagnosed in 55 (45.4%) subjects. Stage 3 plus was the most commonly detected, with a total of 19 cases (15.7%). The disease prevalence showed an inverse relationship to weight and gestational age, being more prevalent among those under 28 WGA and less than 1,000 grams at birth. Conclusions: The prevalence of ROP in our hospital is higher than that reported in other national or international publications, so it is necessary to take actions to prevent further cases.

REFERENCES

1. Secretaría de Salud, Centro Nacional de Equidad de Género y Salud Reproductiva. Lineamiento Técnico. Manejo de la retinopatía del recién nacido prematuro. Octubre 2007.

2. Reyes-Ambriz C, Campuzano-Argüello M, Pardo-Morales RV. Prevalencia de retinopatía en el prematuro. Arch Inv Mat Inf. 2011; 3(3): 132-137.

3. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol. 1984; 102(8): 1130-1134.

4. Carrion JZ, Fortes Filho JB, Tartarella MB, Zin A, Jornada Jr ID. Prevalence of retinopathy of prematurity in Latin America. Clin Ophthalmol. 2011; 5: 1687-1695.

5. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013; 40(2): 185-200.

6. Isaza G, Arora S, Bal M, Chaudhary V. Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada. J Pediatr Ophthalmol Strabismus. 2013; 50(1): 27-32.

7. Flores-Nava G, Barrera VC, De la Fuente MA, Torres NP. Retinopatía del prematuro. Determinación de algunos factores de riesgo. Bol Med Hosp Infant Mex. 2009; 66: 425-430.

8. Orozco-Gómez LP, Ruiz-Morfín I, Lambarry-Arroyo A, Morales-Cruz MV. Prevalencia de retinopatía del prematuro. 12 años de detección en el Centro Médico 20 de Noviembre. Cir Ciruj. 2006; 74(1): 3-9.

9. Zepeda-Romero LC, Aguirre-Jáuregui OM, Angulo-Castellanos E, Gómez-Ruiz LM, Meza-Anguiano A, Quezada-Chalita A et al. Prevalencia de prematuros en riesgo visual y de retinopatía del prematuro tipo uno, en el Hospital Civil de Guadalajara. Rev Med MD. 2013; 4(2): 62-67.

10. Soto-Serrano SJ, Urbina-Cid E. Factores de riesgo relacionados al diagnóstico de retinopatía del prematuro [Tesis]. Ciudad Obregón, Sonora, México: Universidad Autónoma de Sinaloa. Instituto Mexicano del Seguro Social; 2001.

11. International Agency for the Prevention of Blindness. Guidelines for ROP Screening and Treatment in Latin American Countries. 2010.

12. Meraz-Gutiérrez MP, Olguín-Manríquez FJ, Arriola-López AE, Berrones-Medina D, Price KW, Morales-Canton V et al. Evidence to modify guidelines for routine retinopathy of prematurity screening to avoid childhood blindness in middle-income countries. Rev Mex Oftalmol [Internet]. 2016. Available in: http://dx.doi.org/10.1016/j.mexoft.2015.09.005

13. Sears JE, Pietz J, Sonnie C, Dolcini D, Hoppe G. A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity. Ophthalmology. 2009; 116(3): 513-518.